I agree that this site is using cookies. You can find further informations here.
X
Skarbnik, Alan
67  results:
Search for persons X
?
1

Lisocabtagene maraleucel in follicular lymphoma: the phase ..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
2

Hypertension treatment for patients receiving ibrutinib: a ..:

Samples, Laura ; Voutsinas, Jenna ; Fakhri, Bita...
Blood Advances.  8 (2024)  9 - p. 2085-2093 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Activity of venetoclax in patients with relapsed or refract..:

Kater, Arnon P ; Arslan, Önder ; Demirkan, Fatih...
The Lancet Oncology.  25 (2024)  4 - p. 463-473 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Real‐world comparative effectiveness of venetoclax‐obinutuz..:

Ghosh, Nilanjan ; Manzoor, Beenish S. ; Fakhri, Bita...
British Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
5

An indirect comparison of acalabrutinib with and without ob..:

Kittai, Adam S. ; Allan, John N. ; James, Dan...
Blood Advances.  8 (2024)  11 - p. 2861-2869 , 2024
Link: https://doi.org/10.1182/..
 
?
6

Author Correction: Lisocabtagene maraleucel in follicular l..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
7

P647: RACIAL DISPARITIES IN REAL-WORLD TREATMENT PATTERNS A..:

Rhodes, Joanna ; Shadman, Mazyar ; Lamanna, Nicole...
HemaSphere.  7 (2023)  S3 - p. e96103aa , 2023
Link: https://doi.org/10.1097/..
 
?
8

Outcomes among adult recipients of CD19 CAR T-cell therapy ..:

Samples, Laura ; Sadrzadeh, Hossein ; Frigault, Matthew...
International Journal of Cancer Care and Delivery.  3 (2023)  Supplement 2 - p. , 2023
Link: https://doi.org/10.53876..
 
?
9

Treatment Discontinuation Patterns for Patients With Chroni..:

Shadman, Mazyar ; Manzoor, Beenish S. ; Sail, Kavita...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  7 - p. 515-526 , 2023
Link: https://doi.org/10.1016/..
 
?
10

P642: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICA..:

Skarbnik, Alan ; Kittai, Adam ; Miranda, Miguel...
HemaSphere.  7 (2023)  S3 - p. e4236347 , 2023
Link: https://doi.org/10.1097/..
 
?
11

A matching‐adjusted indirect comparison of acalabrutinib ve..:

Kittai, Adam S. ; Skarbnik, Alan ; Miranda, Miguel...
American Journal of Hematology.  98 (2023)  12 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
12

P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CH..:

Lansigan, Frederick ; A. Eyre, Toby ; Ghosh, Nilanjan...
HemaSphere.  7 (2023)  S3 - p. e6855326 , 2023
Link: https://doi.org/10.1097/..
 
?
13

Venetoclax retreatment of patients with chronic lymphocytic..:

Thompson, Meghan C. ; Harrup, Rosemary A. ; Coombs, Catherine C....
Blood Advances.  6 (2022)  15 - p. 4553-4557 , 2022
Link: https://doi.org/10.1182/..
 
?
14

Efficacy and safety in a 4-year follow-up of the ELEVATE-TN..:

Sharman, Jeff P. ; Egyed, Miklos ; Jurczak, Wojciech...
Leukemia.  36 (2022)  4 - p. 1171-1175 , 2022
Link: https://doi.org/10.1038/..
 
?
15

Poster: CLL-139: Acalabrutinib ± Obinutuzumab vs Obinutuzum..:

Sharman, Jeff P. ; Egyed, Miklos ; Jurczak, Wojciech...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S220 , 2021
Link: https://doi.org/10.1016/..
 
1-15